4.7 Article

Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 -, 页码 647-659

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2012.06.017

关键词

Arginine methylation; PRMT; Inhibitor; Near-IR; Fluorescence; Carbocyanine

资金

  1. Georgia Cancer Coalition Distinguished Cancer Scholar Award
  2. NIH [GM086717]
  3. American Heart Association
  4. GSU
  5. Georgia Cancer Coalition Grant
  6. Center for Diagnostics and Therapeutics at Georgia State University

向作者/读者索取更多资源

Protein arginine methylation regulates multiple biological processes. Deregulation of protein arginine methyltransferase (PRMT) activities has been observed in many disease phenotypes. Small molecule probes that target PRMTs with strong affinity and selectivity can be used as valuable tools to dissect biological mechanisms of arginine methylation and establish the role of PRMT proteins in a disease process. In this work, we report synthesis and evaluation of a class of carbocyanine compounds containing indolium, benz[e]indolium or benz[c,d]indolium heterocyclic moieties that bind to the predominant arginine methyltransferase PRMT1 and inhibit its methyltransferase activity at low micromolar potencies. In particular, the developed molecules have long wavelength colorimetric and fluorometric photoactivities, which can be used for optical and near-infrared fluorescence imaging in cells or biological tissues. Together, these new chemical probes have potential application in PRMT studies both as enzyme inhibitors and as fluorescent dyes for microscope imaging. (C) 2012 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Effective Quenchers Are Required to Eliminate the Interference of Substrate: Cofactor Binding in the HAT Scintillation Proximity Assay

Liza Ngo, Jiang Wu, Chao Yang, Yujun George Zheng

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)

Article Chemistry, Medicinal

Exploration of Cyanine Compounds as Selective Inhibitors of Protein Arginine Methyltransferases: Synthesis and Biological Evaluation

Hao Hu, Eric A. Owens, Hairui Su, Leilei Yan, Andrew Levitz, Xinyang Zhao, Maged Henary, Yujun George Zheng

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Multidisciplinary Sciences

A glutamate/aspartate switch controls product specificity in a protein arginine methyltransferase

Erik W. Debler, Kanishk Jain, Rebeccah A. Warmack, You Feng, Steven G. Clarke, Guenter Blobel, Pete Stavropoulos

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Biochemistry & Molecular Biology

Discovery of decamidine as a new and potent PRMT1 inhibitor

Jing Zhang, Kun Qian, Chunli Yan, Maomao He, Brenson A. Jassim, Ivaylo Ivanov, Yujun George Zheng

MEDCHEMCOMM (2017)

Article Chemistry, Analytical

Mass Spectrometric Quantitation of Tubulin Acetylation from Pepsin-Digested Rat Brain Tissue Using a Novel Stable-Isotope Standard and Capture by Anti-Peptide Antibody (SISCAPA) Method

Xiangkun Yang, Sean X. Naughton, Zhen Han, Maomao He, Y. George Zheng, Alvin V. Terry, Michael G. Bartlett

ANALYTICAL CHEMISTRY (2018)

Article Chemistry, Multidisciplinary

A bioorthogonal turn-on fluorescent strategy for the detection of lysine acetyltransferase activity

Maomao He, Zhen Han, Jing Qiao, Liza Ngo, May P. Xiong, Y. George Zheng

CHEMICAL COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

Bisubstrate inhibitors to target histone acetyltransferase 1

Liza Ngo, Tyler Brown, Yujun G. Zheng

CHEMICAL BIOLOGY & DRUG DESIGN (2019)

Article Biochemistry & Molecular Biology

Chemoproteomic Profiling of Protein Substrates of a Major Lysine Acetyltransferase in the Native Cellular Context

Jiabao Song, Liza Ngo, Kaylyn Bell, Y. George Zheng

Summary: This study demonstrates a new method for studying lysine acetyltransferases (KATs) by using a clickable acyl-CoA reporter to acylate proteins. 123 protein substrates of histone acetyltransferase 1 (HAT1) were discovered, expanding our understanding of this important enzyme.

ACS CHEMICAL BIOLOGY (2022)

Article Chemistry, Medicinal

Broad-Spectrum Small-Molecule Inhibitors Targeting the SAM-Binding Site of Flavivirus NS5 Methyltransferase

Subodh Kumar Samrat, Qamar Bashir, Yiding Huang, Carl William Trieshmann, Anil Mathew Tharappel, Ran Zhang, Ke Chen, Y. Geoge Zheng, Zhong Li, Hongmin Li

Summary: This study developed a fluorescence polarization-based high throughput screening (HTS) assay to specifically target the methyltransferase (MTase) and identified two candidate drugs for the treatment of flavivirus infections.

ACS INFECTIOUS DISEASES (2023)

Review Biochemistry & Molecular Biology

Chemical probes and methods for the study of protein arginine methylation

Tyler Brown, Terry Nguyen, Bo Zhou, Y. George Zheng

Summary: Protein arginine methylation is a common post-translational modification in eukaryotic cells that affects various cellular processes. Aberrant expression and activity of protein arginine methyltransferases (PRMTs) have been observed in many diseases, including cancer. Targeting PRMTs has become an attractive therapeutic strategy. This review highlights the chemical aspects of arginine methylation and the development of chemical tools for studying PRMTs and arginine methylation in biology and disease.

RSC CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Pharmacophore-based screening of diamidine small molecule inhibitors for protein arginine methyltransferases

Kun Qian, Chunli Yan, Hairui Su, Tran Dang, Bo Zhou, Zhenyu Wang, Xinyang Zhao, Ivaylo Ivanov, Meng-Chiao Ho, Y. George Zheng

Summary: PRMTs are crucial epigenetic regulators involved in various human diseases, including cancer. Through virtual screening and enzymatic tests, a new potential anticancer inhibitor K313 was discovered, which exhibited significant inhibitory effects on cell proliferation in leukemia cells by targeting PRMT1.

RSC MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Using Chemistry to Target Neuroblastoma

Jeanne N. Hansen, Xingguo Li, Y. George Zheng, Louis T. Lotta, Abhishek Dedhe, Nina F. Schor

ACS CHEMICAL NEUROSCIENCE (2017)

Article Biochemistry & Molecular Biology

Intricate Effects of α-Amino and Lysine Modifications on Arginine Methylation of the N-Terminal Tail of Histone H4

Melody D. Fulton, Jing Zhang, Maomao He, Meng-Chiao Ho, Y. George Zheng

BIOCHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Profiling Cellular Substrates of Lysine Acetyltransferases GCN5 and p300 with Orthogonal Labeling and Click Chemistry

Zhen Han, Chau-wen Chou, Xiangkun Yang, Michael G. Bartlett, Y. George Zheng

ACS CHEMICAL BIOLOGY (2017)

Review Chemistry, Multidisciplinary

Chemical Biology Approaches for Investigating the Functions of Lysine Acetyltransferases

Maomao He, Zhen Han, Liang Liu, Y. George Zheng

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)